CVS Health (CVS) has been on a downward spiral lately with significant selling pressure. After declining 7.7% over the past ...

For CVS, Q2 earnings will be a critical inflection point. A miss could trigger a breakup or further decline, making the stock ...

CVS Health (CVS) is one of the stocks most watched by Zacks.com visitors lately. So, it might be a good idea to review some of the factors that might affect the near-term performance of the stock.

Including the $706 million she disposed of in the first quarter, Safra Catz’s $2.5 billion total makes her the top insider ...

Glenview Capital, a prominent activist investor, has reduced its investment in CVS Health following its robust first-quarter performance. The hedge fund noted a 25% return since initiating its stake ...

Glenview Capital Issues Statement on CVS Health May 06, 2025 4:15 PM ETCVS Health Corporation (CVS) Q1: 2025-05-01 Earnings Summary InsightsTranscript InsightsTranscriptPR EPS of $2.25 beats by $0.58 ...

Activist investor Glenview Capital Management sold 3.75 million shares of CVS Health Corp. — about a third of its stake — and said it was pleased with recent changes at the health care ...

(Reuters) -Activist investor Glenview Capital said on Tuesday it had reduced its holdings in CVS Health (NYSE:CVS) following the insurer’s "healthy" first-quarter results. CVS shares have ...

CVS had been facing pressure from investors, including Glenview, to improve its operations and shareholder value after missing financial targets several times due to increased medical costs in its ...